0001209191-19-050347.txt : 20190920
0001209191-19-050347.hdr.sgml : 20190920
20190920165203
ACCESSION NUMBER: 0001209191-19-050347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190918
FILED AS OF DATE: 20190920
DATE AS OF CHANGE: 20190920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aliski William
CENTRAL INDEX KEY: 0001598426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 191105248
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-18
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001598426
Aliski William
C/O X4 PHARMACEUTICALS, INC.
955 MASSACHUSETTS AVENUE, 4TH FLOOR
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
14.04
2019-09-18
4
A
0
6854
0.00
A
2029-09-18
Common Stock
6854
6854
D
8.3333% of the shares subject to the option shall vest on September 18, 2020, with the remainder vesting in equal monthly installments of 2.7777% of the shares underlying the initial grant until the 36-month anniversary of the date of the grant, subject the Reporting Person's continued service through each applicable vesting date.
/s/ Adam S. Mostafa, Attorney-in-Fact
2019-09-20